Managing low grade and borderline cervical abnormalities

BMJ (Online)

Volumn 339, Issue 7716, 2009, Pages 305-

  Franco, Eduardo L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; EDITORIAL; FEMALE; HUMAN; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DIAGNOSIS; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MASS SCREENING; UTERINE CERVICAL NEOPLASMS;

EID: 69449090920     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3014     Document Type: Editorial

References (8)

1. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009;339:b2546.[Abstract/Free Full Text]
2. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ 2009;339:b2548.[Abstract/Free Full Text]
3. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 2009;339:b2549.[Abstract/ Free Full Text]
4. Anonymous. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.[Abstract/Free Full Text]
5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D; 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-355[CrossRef] [Web of Science][Medline]
6. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299[Abstract/Free Full Text] (Pubitemid 32219816)
7. Ronco G, Arbyn M, Segnan N. Influence of HPV infection and age on the effectiveness of cervical screening. BMJ 2009;339:b3005.[Free Full Text]
8. Castle PE, Rodrìguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 2009;339:b2569. [Abstract/Free Full Text]